Prof. Hong Jae Chon has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Eisai, Roche, ONO, MSD, Bristol Myers Squibb, BeOne Medicines, Sanofi, Servier, AstraZeneca, Boryung, and Chugai; has served as a consultant or advisory board member for Eisai, Roche, ONO, MSD, Bristol Myers Squibb, BeOne Medicines, Servier, AstraZeneca, Boryung, IMBDx, Aptamer Science, and Bayer; and has received research grants from Roche, BeOne Medicines, IMBDx, Dong-A ST, Boryung, Medivir, Guardant Health, Servier, and Handok. He has also received travel, accommodation, or expense support from Medivir and Chugai.